Upregulated SLC27A2/FATP2 in differentiated thyroid carcinoma promotes tumor proliferation and migration
Open Access
- 2 December 2021
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (1) , e24148
Abstract
Background: Differentiated thyroid carcinoma (DTC) accounts for the vast majority of thyroid cancer (TC) cases. The rapidly increasing incidence of TC requires the urgent identification of new diagnostic and therapeutic targets. Solute carrier family 27 member 2 (SLC27A2/FATP2) plays an essential role in lipid biosynthesis and fatty acid transport. Recent studies have confirmed its involvement in a variety of diseases, including cancer.Methods: In this study, the expression of SLC27A2 was analyzed in cancer and paracancerous tissue samples from 98 thyroid cancer patients, and we performed ROC analysis to confirm the diagnostic value. CCK8, Transwell, and other methods were used to study its effect on DTC, and the mechanism of SLC27A2 was investigated by RNA sequencing and Western blot.Results: The expression of SLC27A2 was upregulated in both DTC tissues and cell lines and was correlated with clinical progression. In vitro studies further confirmed that SLC27A2 knockdown attenuated the proliferation and invasion of DTC cells. Through RNA sequence analysis and gene set enrichment analysis, we found that the MAPK pathway is the main downstream signaling pathway for the regulation by SLC27A2. SLC27A2 affects cell proliferation and differentiation by inducing changes in the proto‐oncogene C‐FOS.Conclusions: Our results show that SLC27A2 plays an important role in tumor proliferation and migration, providing a new putative target for the diagnosis and treatment of TC.Keywords
This publication has 28 references indexed in Scilit:
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Targeting lipid metabolism for the treatment of anaplastic thyroid carcinomaExpert Opinion on Therapeutic Targets, 2015
- Definition and management of radioactive iodine-refractory differentiated thyroid cancerThe Lancet Diabetes & Endocrinology, 2014
- Prognosis and prognostic factors of differentiated thyroid carcinoma after the appearance of metastasis refractory to radioactive iodine therapyEndocrine Journal, 2014
- Hepatic Fatty Acid Trafficking: Multiple Forks in the RoadAdvances in Nutrition, 2013
- Molecular pathogenesis and mechanisms of thyroid cancerNature Reviews Cancer, 2013
- Fatty acid transport proteins, implications in physiology and diseaseBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Cervical lymph node metastasis and papillary thyroid carcinoma: Does the compartment involved affect survival? Experience from the SEER databaseJournal of Surgical Oncology, 2012
- Thyroid carcinomaThe Lancet, 2003
- Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro.1953